Work

Updated safety and clinical activity results from a phase Ib study of atezolizumab + bevacizumab in hepatocellular carcinoma (HCC)

Year: 2018

Type: article

Study design: Clinical Trial

Source: Annals of Oncology

DOI: 10.1093/annonc/mdy424.028

Authors: M.J. Pishvaian, M.S. Lee, B.-Y. Ryoo, S. Stein, K.-H. Lee, W. Verret, J. Spahn, H. Shao, B. Liu, K. Iizuka, C.-H. Hsu

Institutions: Georgetown University, University of North Carolina at Chapel Hill, UNC Lineberger Comprehensive Cancer Center, Asan Medical Center, University of Ulsan, Yale University, Seoul National University Hospital, Genentech, Roche (China), National Taiwan University Hospital

Language: English

Topic: Hepatocellular Carcinoma Treatment and Prognosis

Subfield: Hepatology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

Funder: Eli Lilly and Company

OpenAlex ID: W2898130255

FWCI: 8.933

Cites:

Cited by: 76

Related to: 10